Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.
Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.
What if better research approaches could help take the “unknown” out of chronic kidney disease of unknown etiology (CKDu)? Launched at WCN’26, the new ISN i3C CKDu Toolkit* is designed to help build research capacity in CKDu-endemic regions by strengthening study design and implementation through consistent approaches to case definitions, exposure assessment, and outcome measurement. Explore the ISN i3C Toolkit It offers practical guidance to strengthen the rigor,...
From unmet needs in immune-mediated kidney diseases to therapeutic advances in C3G, WCN’26 Industry Sessions explored some of the most pressing topics in global kidney care today. Session recordings are open access and available on demand at the ISN Academy. Explore all industry symposia at the ISN Academy Discover dozens of sessions offering fresh perspectives on emerging science and new developments to help you stay up to date...
Ten years ago, Kidney International Reports® (KIR) launched with a clear mission: to expand access to high-quality kidney research and ensure that important discoveries reach clinicians, researchers, and health systems worldwide. Over the past decade, the journal has published studies that have shaped care and policy, fostered opportunities for early-career researchers to contribute and collaborate, and elevated voices...
The 44th Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology 2026 will take place from June 16-18, 2026, at the Vicenza International Convention Centre in Vicenza, Italy. This hands-on course for beginner and advanced kidney care professionals explores the latest advances in acute kidney injury, from diagnosis and treatment strategies to emerging therapies to help prevent progression to chronic kidney disease. Explore the preliminary scientific...
The ISN “Are your kidneys healthy?” quiz webpage has been refreshed with a new design that makes key kidney health information easier to explore. Access the “Are your kidneys healthy?” quiz Available in 35 languages, the quiz helps better understand kidney function, risk factors, and steps they can take to protect their kidney health. Share the quiz with your patients to open a dialogue about...
The winning film* of the ISN Community Film Event, “Aurenis Choir: A Song of Hope” is a moving story from Argentina that reminds us that kidney care is not only about medicine, but also about connection, creativity, and hope. The Aurenis Choir was founded on World Kidney Day 2024 with the aim of creating a space for community, art, and meaning alongside...
Kidney International® Modern challenges in infection prevention: encapsulated organisms in the era of novel complement inhibitors This mini review examines infection prevention in patients receiving novel complement inhibitors, with a focus on serious infections caused by encapsulated organisms. It outlines practical strategies, including vaccination, antibiotic prophylaxis, and patient education. The authors stress that these therapies offer important benefits...
The ISN’s new IgA Nephropathy Curriculum delivers timely, practice-focused insights to help you integrate emerging evidence into care and optimize outcomes. Access the curriculum at the ISN Academy The curriculum is organized into three core areas of IgAN: pathogenesis, treatment, and prediction. Each section features in-depth conversations with David Wheeler, Jonathan Barret, and Michelle O'Shaughnessy, conducted...
The ISN-led GREEN-K* (Global Environmental Evolution in Nephrology and Kidney Care) initiative invites the global kidney community to review and comment on a joint draft statement, “Procurement for Environmentally and Ethically Sound Kidney Care Products and Services.” Read the draft statement and share your feedback by...
Kidney International® A single-arm phase 2 trial of an investigational RNA therapeutic targeting complement factor B (sefaxersen) for treatment of IgA nephropathy IgA nephropathy (IgAN) involves activation of the complement alternative pathway, contributing to kidney inflammation and disease progression. In this global, open-label phase 2 trial, patients with biopsy-confirmed IgAN received sefaxersen, an antisense inhibitor of complement factor B, to...
In Japan, the art of kintsugi repairs broken pottery with adhesive and powdered gold, transforming fracture into renewed strength. As the global kidney care community prepares to gather in Yokohama for WCN’26, Japan’s approach to kidney health offers a compelling parallel: working with impairment to preserve function, extending quality of life in an aging society, and continuously strengthening systems of care through early detection and...
Looking to strengthen your confidence in diagnosing and managing glomerular diseases? The ISN Primer Course in Glomerular Diseases offers an intensive, case-based learning experience designed to sharpen clinical decision-making and connect you with international faculty and peers. Applications are now open for the next edition of the course in Montevideo, Uruguay, from August 8–9, 2026. Find...
From Africa to East Asia, ISN leaders are engaging with regional kidney care communities this March, sharing expertise, training opportunities, and strengthening connections that help advance equitable kidney care worldwide. Ethiopian Kidney Association’s 2nd Annual Nephrology Conference March 7, 2026 Addis Ababa, Ethiopia Robert Walker, chair of the ISN Core Programs Committee, will present virtually on ISN Grants, outlining pathways for ISN members to access support and build local capacity. Japan Kidney Masterclass March 7, 2026 Tokyo, Japan Hosted by the Japanese Society of Nephrology, the masterclass will...
Do you have a clinical research question on how to improve kidney care in your region? The ISN Clinical Research Program (CRP) helps clinicians turn local priorities into publishable evidence, providing funding and support to launch meaningful studies. Applicants must submit a short abstract to the relevant ISN Regional Coordinator by March 1. Find out more and apply Rumbidzai Dahwa received a CRP grant in 2017 to study the prevalence...
Virtual registration brings the World Congress of Nephrology 2026 straight to you, no matter where you are. As a virtual delegate, you get access to live streaming of all 13 sessions in the Main Hall (Plenary Hall) from March 28–31, with live transcriptions in Japanese and English and more than 50 other languages. You will also have access to over 100 hours of...
Every nephrologist has encountered a case that stayed with them, one that challenged assumptions, raised new questions, or changed how they approach care. Turning that experience into a case report is not about including every detail, but about sharing the clinical lesson that others can apply. Submit your case report to KICR Kidney International Case Reports™...
For many nephrologists, an ISN Fellowship is more than advanced training; it is a turning point in what becomes possible for patients and kidney care teams back home. “The ISN Fellowship program represented a pivotal moment in my professional journey,” reflects Christina Amira (Nigeria), ISN Fellow from 2003–2004. “Upon returning to my home country, I successfully established a...
How will you support kidney health and sustainability this World Kidney Day? With kidney disease affecting millions worldwide and environmental factors such as heat, pollution, and access to clean water increasingly shaping risk, this year’s theme, “Kidney Health for All: Caring for People, Protecting the Planet,” calls for prevention, early detection, and care models that are people-centered and planet-conscious. Read...
Kidney International® A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease This randomized, double-blind trial evaluated whether pravastatin could slow disease progression in adults with early autosomal dominant polycystic kidney disease (ADPKD) and preserved kidney function. Researchers followed 150 participants receiving pravastatin or a placebo...
Who can access the evidence that informs practice, and how quickly does that evidence reach the bedside? As Kidney International Reports® (KIR) celebrates its 10th anniversary throughout 2026, these two questions are as pertinent as ever for clinicians and researchers working in kidney care. Reflections from KIR’s Editor-in-Chief Jai Radhakrishnan and Deputy Editor Sumit Mohan highlight how the journal’s editorial decisions, including a commitment to open access and a focus on practice-relevant research, have supported wider access...
